Answers are grounded in this paper and cite their sources.
This retrospective analysis reveals lipid profile changes in individuals treated for hepatitis B, indicating potential metabolic health issues.
TDF causes a decrease in LDL levels, TC and total cholesterol/HDL ratio. However, use of ETV and TAF did not significantly affect the lipid profile. It should not be forgotten that lipid profile changes may cause metabolic health problems in individuals receiving hepatitis B treatment and appropriate treatment should be planned by regular monitoring according to treatment groups.
No takes yet. Share an insight, caveat, or question.
Karabay et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: